6th Annual Midwest Tumor Microenvironment Meeting

第六届中西部肿瘤微环境年会

基本信息

批准号：
10002411
负责人：
Shrikant Anant
金额：
$ 0.5万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-05-01 至 2023-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10002411
关键词：
Address Affect Area Basic Science Biology Career Mobility Child Care Cities Clinical Clinical Trials Collaborations Colorado Cytoskeleton Data Disabled Persons Doctor of Philosophy Emerging Technologies Ensure Extracellular Matrix Faculty Fostering Funding Funding Opportunities Gender Goals Growth Illinois Immune system Immunologist Immunosuppression In Vitro Indiana Individual Institutes Iowa Kansas Laboratories Leadership Learning Malignant Neoplasms Medical Medical center Mentors Michigan Midwestern United States Minnesota Minority Minority Recruitment Missouri Modality Modeling National Cancer Institute Nebraska Ohio Oklahoma Oral Organoids Participant Patients Postdoctoral Fellow Pre-Clinical Model Preventive Research Research Personnel Role Rural Community Science Scientist South Dakota Thinking Training Translational Research Tumor Biology Universities Visit Wisconsin Woman Work base career career development career networking cost design ethnic minority population exosome experience graduate student immune function improved in vivo interest knowledge base lectures meetings multidisciplinary new technology novel diagnostics posters programs racial minority response skills symposium translational scientist treatment strategy tumor tumor growth tumor microenvironment tumor progression tumorigenesis undergraduate student

项目摘要

Project Summary We request partial funding for the Midwest Tumor Microenvironment Meeting to be held at the University of Kansas Medical Center in Kansas City, KS on May 18-20, 2020. The meeting was inaugurated in 2015 and is the only meeting on tumor microenvironment in the Midwest region. This meeting has established itself as a highly valued contribution to the interdisciplinary scientific field of the tumor microenvironment, with focus on the role of immune system and the stroma in cancer growth and progression. The 2020 conference co-organizers are Shrikant Anant, Ph.D. and Sufi M. Thomas, Ph.D. The meeting will convene 18 speakers and up to 200 participants. A special effort will be made to recruit minority participants. The meeting will also provide a forum for trainees and scientists who are in early stages of their career to present their data and network with others in the field. Dr. David Tuveson from the Cold Spring Harbor Laboratory, an expert in exploring the fundamental biology of malignancy and thereby identify new diagnostic and treatment strategies will present his recent work on patient-derived organoid models. In addition, Dr. Theresa Whiteside from the University of Pittsburgh Medical Center, who investigates the role of the immune function in tumorigenesis will present her recent work on stroma- derived exosomes and their role in tumorigenesis in her keynote address. Topics for presentation will be multi- disciplinary including novel technologies to study issues related to tumor-stroma interactions, as well as the various cellular and extracellular matrix factors affecting tumorigenesis. In addition to invited speakers, trainees and young investigators will have the opportunity to present in oral presentation sessions. In addition, there will be two poster sessions, which will allow all participants to contribute to the meeting. Opportunities will especially be given to your investigators, women, and minorities to interact with the presenting faculty and representatives from the National Cancer Institute Tumor Microenvironment Program. Funding through this R13 mechanism is requested to defray the cost of participating in the meeting for young investigators and trainees. We expect that researchers dealing with various aspects of the tumor microenvironment will cultivate new collaborations and the trainees will identify new mentors as a result of the networking opportunity from this meeting.

项目概要我们请求为在大学举行的中西部肿瘤微环境会议提供部分资金 2020 年 5 月 18 日至 20 日在堪萨斯州堪萨斯城堪萨斯医疗中心举行。会议于 2015 年开幕，中西部地区唯一关于肿瘤微环境的会议。这次会议将其定位为对肿瘤微环境跨学科科学领域的高度评价贡献，重点关注免疫系统和基质在癌症生长和进展中的作用。 2020年会议协办单位是 Shrikant Anant 博士。和苏菲·M·托马斯博士会议将召集 18 名发言人和最多 200 人参与者。将特别努力招募少数族裔参与者。会议还将提供论坛供处于职业生涯早期阶段的学员和科学家展示他们的数据并与其他人建立联系领域。冷泉港实验室 David Tuveson 博士，探索基本原理的专家恶性肿瘤生物学，从而确定新的诊断和治疗策略将介绍他最近的工作源自患者的类器官模型。此外，匹兹堡大学医学院的 Theresa Whiteside 博士研究免疫功能在肿瘤发生中的作用的中心将介绍她最近在基质方面的工作她的主题演讲中介绍了衍生的外泌体及其在肿瘤发生中的作用。演讲主题将是多方面的学科包括研究与肿瘤-基质相互作用相关问题的新技术，以及影响肿瘤发生的各种细胞和细胞外基质因素。除了特邀演讲者之外，还有实习生年轻的研究人员将有机会在口头报告会上进行发言。此外，还将有举办两次海报会议，让所有参与者都能为会议做出贡献。机会尤其会供您的研究人员、女性和少数族裔与出席的教师和代表互动来自国家癌症研究所肿瘤微环境项目。通过此 R13 机制提供的资金是要求支付年轻研究者和实习生参加会议的费用。我们期望处理肿瘤微环境各个方面的研究人员将培养新的合作和受训者将通过本次会议的交流机会确定新的导师。